Phyton Biotech LLC

Phyton commercially supplies docetaxel API (anhydrous). It is inspected by: USP/EP, US DMF 24675, CEP 2012-105, filed in Japan, Korea, China, India. Contact us for more information.

Phyton commercially supplies paclitaxel API (from Plant Cell Fermentation PCF™). It is inspected by: USP/EP, CEP 2011-324, US DMF 25525, filed in Japan, Korea, China, India. Contact us for more information.

Phyton Biotech (www.phytonbiotech.com), the worlds largest provider of Plant Cell Fermentation technology, produces paclitaxel and docetaxel and offers comprehensive development and manufacturing services of other plant-based molecules, extracts and recombinant products for use in the Pharmaceutical, Traditional Chinese Medicine (TCM), Cosmetic, Agricultural and Food Ingredient industries. Phyton Biotech has the expertise and GMP facilities in both Germany and Canada to carry out every step required for a full development program — from first plant cell to scale-up.

Phyton Biotech develops and applies sustainable and “green” chemistry manufacturing solutions for phytochemicals using PCF®️, serving the Pharmaceutical, Traditional Chinese Medicine (TCM), Cosmetic, Agricultural and Food Ingredient industries. Utilizing our revolutionary PCF®️ platform, Phyton offers a time, risk, and cost-balanced path to commercially viable production processes. With certified GMP facilities in Germany and Canada, Phyton combines highly developed technology and quality to meet our global customers’ needs. We have a successful track record of developing and implementing innovative contract development solutions for clients around the world.

Access the brochure now to explore Phyton Biotech's Speciality Fermentation Solutions.